KR20230121960A - 테르페노페놀 화합물 및 이의 용도 - Google Patents
테르페노페놀 화합물 및 이의 용도 Download PDFInfo
- Publication number
- KR20230121960A KR20230121960A KR1020227037909A KR20227037909A KR20230121960A KR 20230121960 A KR20230121960 A KR 20230121960A KR 1020227037909 A KR1020227037909 A KR 1020227037909A KR 20227037909 A KR20227037909 A KR 20227037909A KR 20230121960 A KR20230121960 A KR 20230121960A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- cbd
- pet
- diol
- prop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
- C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003270P | 2020-03-31 | 2020-03-31 | |
| US63/003,270 | 2020-03-31 | ||
| PCT/GB2021/050812 WO2021198692A1 (en) | 2020-03-31 | 2021-03-31 | Terpenophenolic compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230121960A true KR20230121960A (ko) | 2023-08-22 |
Family
ID=75426633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227037909A Pending KR20230121960A (ko) | 2020-03-31 | 2021-03-31 | 테르페노페놀 화합물 및 이의 용도 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12552733B2 (enExample) |
| EP (1) | EP4126800A1 (enExample) |
| JP (1) | JP7714571B2 (enExample) |
| KR (1) | KR20230121960A (enExample) |
| CN (1) | CN116194431B (enExample) |
| AU (1) | AU2021248627A1 (enExample) |
| BR (1) | BR112022019616A2 (enExample) |
| GB (3) | GB2628746A (enExample) |
| IL (1) | IL296861A (enExample) |
| MX (1) | MX2022011832A (enExample) |
| WO (1) | WO2021198692A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3959193A4 (en) * | 2019-05-23 | 2022-07-13 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136839A (en) * | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| EP2578561A1 (en) | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Processes for the production of cannabidiol derivatives and intermediates thereof |
| AU2012201041B2 (en) * | 2005-09-29 | 2012-12-06 | Albany Molecular Research, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| DE102009019322A1 (de) | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| WO2014177593A1 (en) | 2013-04-29 | 2014-11-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Amorfrutin analogs as ppargamma-modulators |
| US9526706B1 (en) | 2015-06-16 | 2016-12-27 | Hong Kong Baptist University | Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury |
| US9738581B2 (en) * | 2015-06-16 | 2017-08-22 | Hong Kong Baptist University | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| US20170008869A1 (en) * | 2015-07-10 | 2017-01-12 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| CN109311838A (zh) | 2016-04-15 | 2019-02-05 | 蒂温诺特技术有限公司 | 大麻素前药的生物合成 |
| US20170362195A1 (en) | 2016-06-16 | 2017-12-21 | Full Spectrum Laboratories Ltd | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use |
| US10640482B2 (en) | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| CN111372907A (zh) | 2017-09-01 | 2020-07-03 | 普优峰全球股份有限公司 | 合成大麻二酚组合物和用于制备其的方法 |
| DE102017008367B4 (de) * | 2017-09-06 | 2019-06-13 | Sumitomo Wiring Systems, Ltd. | Abschirmverbinder und Verfahren zum Zusammenbauen desselben |
| EP3840854A4 (en) * | 2018-08-20 | 2022-06-29 | Bessor Pharma, LLC | Novel cannabinoids and cannabinoid acids and their derivatives |
| EP3959193A4 (en) * | 2019-05-23 | 2022-07-13 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
| CA3150642A1 (en) * | 2019-09-09 | 2021-03-18 | Kamaluddin Abdur-Rashid | CANNABINOID DERIVATIVES, PRECURSORS AND USES |
| CA3150646A1 (en) * | 2019-09-10 | 2021-03-18 | Kamaluddin Abdur-Rashid | CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRICAL SYNTHESIS THEREOF |
-
2021
- 2021-03-31 CN CN202180038597.7A patent/CN116194431B/zh active Active
- 2021-03-31 GB GB2410277.4A patent/GB2628746A/en not_active Withdrawn
- 2021-03-31 MX MX2022011832A patent/MX2022011832A/es unknown
- 2021-03-31 JP JP2022560311A patent/JP7714571B2/ja active Active
- 2021-03-31 GB GB2104690.9A patent/GB2595355A/en not_active Withdrawn
- 2021-03-31 EP EP21717177.6A patent/EP4126800A1/en active Pending
- 2021-03-31 KR KR1020227037909A patent/KR20230121960A/ko active Pending
- 2021-03-31 WO PCT/GB2021/050812 patent/WO2021198692A1/en not_active Ceased
- 2021-03-31 BR BR112022019616A patent/BR112022019616A2/pt unknown
- 2021-03-31 AU AU2021248627A patent/AU2021248627A1/en active Pending
- 2021-03-31 GB GB2215746.5A patent/GB2609814B/en active Active
- 2021-03-31 US US17/916,494 patent/US12552733B2/en active Active
- 2021-03-31 IL IL296861A patent/IL296861A/en unknown
-
2022
- 2022-09-30 US US17/958,083 patent/US20230225985A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB2609814A (en) | 2023-02-15 |
| MX2022011832A (es) | 2023-03-03 |
| GB2595355A (en) | 2021-11-24 |
| WO2021198692A1 (en) | 2021-10-07 |
| CN116194431B (zh) | 2026-01-02 |
| CA3177186A1 (en) | 2021-10-07 |
| IL296861A (en) | 2022-11-01 |
| CN116194431A (zh) | 2023-05-30 |
| AU2021248627A1 (en) | 2022-12-01 |
| EP4126800A1 (en) | 2023-02-08 |
| US20230227390A1 (en) | 2023-07-20 |
| US20230225985A1 (en) | 2023-07-20 |
| GB202410277D0 (en) | 2024-08-28 |
| JP7714571B2 (ja) | 2025-07-29 |
| US12552733B2 (en) | 2026-02-17 |
| GB2628746A (en) | 2024-10-02 |
| GB2609814B (en) | 2024-08-28 |
| GB202104690D0 (en) | 2021-05-12 |
| JP2023520794A (ja) | 2023-05-19 |
| GB202215746D0 (en) | 2022-12-07 |
| BR112022019616A2 (pt) | 2022-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20230122083A (ko) | 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법 | |
| TWI451870B (zh) | 脂肪酸醯胺水解酶抑制劑 | |
| KR20230121808A (ko) | 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법 | |
| EP2760444B1 (de) | Cannabinoidcarbonsäuren, salze von cannabinoidcarbonsäuren, deren herstellung und anwendungen | |
| EP2970184B1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
| Cannon et al. | Centrally acting emetics. 6. Derivatives of. beta.-naphthylamine and 2-indanamine | |
| KR20240007185A (ko) | 간질 치료를 위한 칸나비디올-c4의 유도체 | |
| JPH0684336B2 (ja) | 殺生物性芳香族化合物、その合成および医薬としてのその使用 | |
| EP4190782A1 (en) | Biphenyl compound as immunomodulator, preparation method therefor and application thereof | |
| EP0711272A1 (en) | Indane and tetrahydronaphthalene derivatives as calcium channel antagonists | |
| JP7714571B2 (ja) | テルペンフェノール化合物およびそれらの使用 | |
| DE60121809T2 (de) | Materialien und verfahren zur herstellung von stilbenen | |
| US7026516B2 (en) | Compounds with high monoamine transporter affinity | |
| EP2121571A1 (de) | Fluorsubstituierte amphetamine und amphetaminderivate und deren verwendung | |
| FI77840C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara resorcinderivat. | |
| JP2007506714A (ja) | 神経向性薬として利用可能なハイドロキシル化された長鎖をもつトコフェノール誘導体 | |
| CN113521038A (zh) | 一种麻醉药物组合物及其应用 | |
| CN109415285B (zh) | 苯双酚衍生物及其制备方法和在医药上的应用 | |
| US7935726B1 (en) | Tricyclic pyrones | |
| KR101840178B1 (ko) | 〔２.２.２〕비시클릭 유도체 및 사용방법 | |
| KR100398055B1 (ko) | 항산화 활성을 가지는 퀴논 화합물 | |
| US7763650B2 (en) | Pharmaceutical compound and method | |
| Jordan | The synthesis of GdB-texaphyrins as novel multipurpose cancer drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11 | Administrative time limit extension requested |
Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |